Skip to main content
Home

Main navigation

  • Home
  • News
  • About HIV
  • About us
  • Donate
Search
Donate now

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you.

I am a UK taxpayer and I understand that if I pay less Income and /or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in the relevant tax year, it is my responsibility to pay any difference.

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness.

  • £5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment.
  • £10 helps us produce news and bulletins on the latest developments in HIV for healthcare staff around the world.
  • £35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts.
Conferences

25th Annual BHIVA conference – 2019

The 25th Annual Conference of the British HIV Association (BHIVA) took place in Bournemouth, UK from 2 to 5 April.
Undetectable viral load & treatment as prevention

Most UK clinic staff now tell people about U=U, but not always in the same way

29 April 2019
Infant feeding

Breastfeeding with an undetectable viral load: some insights into the current UK situation

26 April 2019
Transgender people

First data on trans people accessing HIV care in England

23 April 2019
Ethnic & cultural minorities

Older black HIV-positive women have more mental distress than other women with HIV, but get less help for it

17 April 2019
Hepatitis C transmission & prevention

English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative

7 April 2019
PrEP science

Raltegravir plus lamivudine is likely to work as PrEP

5 April 2019
Sign up for our email bulletins.
Sign up

Editors’ picks from other sources

Treatment simplification strategies

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks

SWORD studies demonstrate long-term durable efficacy and tolerability of Juluca, the first complete 2-drug regimen, for the treatment of virologically suppressed adults with HIV
ViiV press release
5 Apr 19
More editors' picks

Visit the official conference website

About us

Our information is intended to support, rather than replace, consultation with a healthcare professional.

Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

Connect with us

  • Twitter
  • Facebook
  • YouTube
  • Instagram

Links

Show — Links Hide — Links
  • Contact us
  • THT Direct Helpline
  • Subscribe to email bulletins

 

aidsmap (previously known as NAM aidsmap) is now hosted by Terrence Higgins Trust, an HIV charity based in the United Kingdom.

 

Copyright 2025 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527) Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 437 & 439 Caledonian Road, London, N7 9BG.

Footer menu

Show — Footer menu Hide — Footer menu
  • Accessibility
  • Compliment, complaint or concern
  • Our information
  • Privacy & cookies
  • Terms of use
  • Terrence Higgins Trust